{"title":"Effect of conditioning intensity on late complications in AYA who underwent allogeneic HCT during childhood.","authors":"Maiko Shimomura, Miho Ashiarai, Itaru Kato, Takahiro Kamiya, Nanami Taketomi, Tomoyuki Akita, Yasushi Orihashi, Hiroshi Kawaguchi, Katsutsugu Umeda","doi":"10.1007/s12185-025-03961-x","DOIUrl":null,"url":null,"abstract":"<p><p>We retrospectively analyzed the effect of conditioning intensity on 22 late complications in 145 adolescent and young adults who underwent allogeneic hematopoietic cell transplantation (HCT) in childhood. Seventy-six patients received myeloablative conditioning (MAC), while 69 received reduced-intensity conditioning (RIC). Incidence rates of late complications (≥ 1), organ dysfunction, endocrine/metabolic abnormalities, and psychosocial issues in evaluable patients were 71.0%, 17.2%, 66.2%, and 9.0%, respectively. The prevalence of short stature, impaired glucose tolerance, dyslipidemia, and gonadal dysfunction was significantly higher in the MAC group than in the RIC group. Multivariate analyses identified conditioning regimen as an independent factor for gonadal dysfunction and impaired glucose tolerance, but not for short stature. In contrast, inverse probability of treatment weighting analysis revealed that the prevalence of not only gonadal dysfunction and impaired glucose tolerance, but also of short stature, was significantly higher in the MAC group than in the RIC group. The prevalence of organ dysfunction, secondary malignancies, and psychological issues did not differ significantly between the two groups. Reducing conditioning intensity significantly influenced various endocrine complications but not organ dysfunction or psychosocial issues. These findings will inform selection of optimal conditioning regimens and development of practical long-term follow-up systems for pediatric HCT recipients.</p>","PeriodicalId":13992,"journal":{"name":"International Journal of Hematology","volume":" ","pages":""},"PeriodicalIF":1.7000,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Hematology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12185-025-03961-x","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
We retrospectively analyzed the effect of conditioning intensity on 22 late complications in 145 adolescent and young adults who underwent allogeneic hematopoietic cell transplantation (HCT) in childhood. Seventy-six patients received myeloablative conditioning (MAC), while 69 received reduced-intensity conditioning (RIC). Incidence rates of late complications (≥ 1), organ dysfunction, endocrine/metabolic abnormalities, and psychosocial issues in evaluable patients were 71.0%, 17.2%, 66.2%, and 9.0%, respectively. The prevalence of short stature, impaired glucose tolerance, dyslipidemia, and gonadal dysfunction was significantly higher in the MAC group than in the RIC group. Multivariate analyses identified conditioning regimen as an independent factor for gonadal dysfunction and impaired glucose tolerance, but not for short stature. In contrast, inverse probability of treatment weighting analysis revealed that the prevalence of not only gonadal dysfunction and impaired glucose tolerance, but also of short stature, was significantly higher in the MAC group than in the RIC group. The prevalence of organ dysfunction, secondary malignancies, and psychological issues did not differ significantly between the two groups. Reducing conditioning intensity significantly influenced various endocrine complications but not organ dysfunction or psychosocial issues. These findings will inform selection of optimal conditioning regimens and development of practical long-term follow-up systems for pediatric HCT recipients.
期刊介绍:
The International Journal of Hematology, the official journal of the Japanese Society of Hematology, has a long history of publishing leading research in hematology. The journal comprises articles that contribute to progress in research not only in basic hematology but also in clinical hematology, aiming to cover all aspects of this field, namely, erythrocytes, leukocytes and hematopoiesis, hemostasis, thrombosis and vascular biology, hematological malignancies, transplantation, and cell therapy. The expanded [Progress in Hematology] section integrates such relevant fields as the cell biology of stem cells and cancer cells, and clinical research in inflammation, cancer, and thrombosis. Reports on results of clinical trials are also included, thus contributing to the aim of fostering communication among researchers in the growing field of modern hematology. The journal provides the best of up-to-date information on modern hematology, presenting readers with high-impact, original work focusing on pivotal issues.